Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

Presentation TCT 2020

Five-Year Follow-Up from the PARTNER 2 Aortic Valve-in-Valve Registries: Clinical Outcomes, Valve Function, and Durability

Presenter: Rebecca T. Hahn

October 17, 2020

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Conference News TCT 2018

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TCT Daily Staff

September 28, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve

Presenter: John G. Webb

September 23, 2018

Presentation TCT 2016

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, Pamela S. Douglas

November 01, 2016

Presentation TCT 2016

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen

November 01, 2016

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Conference News TCT 2015

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

October 11, 2015

News Conference News TCT 2015

Global TAVR Market Poised to Exceed DES Market by 2025

October 11, 2015

News Conference News TCT 2015

Asian TAVR Registry Shows Good Procedural and Clinical Results

October 11, 2015

Presentation TCT 2014

TCT 699: The Effect of Tricuspid Regurgitation and Right Ventricular Dysfunction on Mortality in High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER II Inoperable Cohort

Presenter: James B. Hermiller Jr, Susheel Kodali, Augusto D. Pichard, Alan Zajarias

September 16, 2014

Presentation TCT 2014

Case Presentation #2: Aortic Stenosis in an Intermediate-Risk Patient

Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Adolfo G López Campanher

September 13, 2014

Presentation TCT 2014

TAVR in a High-Risk Woman with Difficult Vascular Access

Presenter: Thierry Corcos, George D. Dangas, Ahmed Magdy, Raj Makkar

September 13, 2014

Advertisement

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Five-Year Follow-Up from the PARTNER 2 Aortic Valve-in-Valve Registries: Clinical Outcomes, Valve Function, and Durability

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

High Mortality but Durable Results With Valve-in-Valve TAVR

PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

Global TAVR Market Poised to Exceed DES Market by 2025

Asian TAVR Registry Shows Good Procedural and Clinical Results

TCT 699: The Effect of Tricuspid Regurgitation and Right Ventricular Dysfunction on Mortality in High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER II Inoperable Cohort

Case Presentation #2: Aortic Stenosis in an Intermediate-Risk Patient

TAVR in a High-Risk Woman with Difficult Vascular Access

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content